These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35167895)

  • 1. The effects of estrogen on targeted cancer therapy drugs.
    Zhao Y; Wang X; Liu Y; Wang HY; Xiang J
    Pharmacol Res; 2022 Mar; 177():106131. PubMed ID: 35167895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
    Wu W; Xue X; Chen Y; Zheng N; Wang J
    Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ERα36 in cell type-specific functions of estrogen and cancer development.
    Mahboobifard F; Dargahi L; Jorjani M; Ramezani Tehrani F; Pourgholami MH
    Pharmacol Res; 2021 Jan; 163():105307. PubMed ID: 33246174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance.
    Mansouri S; Farahmand L; Hosseinzade A; Eslami-S Z; Majidzadeh-A K
    Biomed Pharmacother; 2017 Sep; 93():1320-1325. PubMed ID: 28747013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
    Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan: 25 years of cancer treatment.
    Bailly C
    Pharmacol Res; 2019 Oct; 148():104398. PubMed ID: 31415916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
    Chen F; Qin X; Xu G; Gou S; Jin X
    Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting LRP6: A new strategy for cancer therapy.
    Xue W; Zhu B; Zhao K; Huang Q; Luo H; Shou Y; Huang Z; Guo H
    Pharmacol Res; 2024 Jun; 204():107200. PubMed ID: 38710241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy as a molecular target for cancer treatment.
    Kocaturk NM; Akkoc Y; Kig C; Bayraktar O; Gozuacik D; Kutlu O
    Eur J Pharm Sci; 2019 Jun; 134():116-137. PubMed ID: 30981885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention.
    He W; Zhang S; Qi Z; Liu W
    Pharmacol Res; 2024 Jun; 204():107201. PubMed ID: 38704108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.
    Ko JC; Chiu HC; Syu JJ; Jian YJ; Chen CY; Jian YT; Huang YJ; Wo TY; Lin YW
    Biochem Pharmacol; 2014 Mar; 88(1):119-27. PubMed ID: 24447935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.
    Barbolina MV
    Pharmacol Res; 2021 Jun; 168():105585. PubMed ID: 33798735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.
    Lernoux M; Schnekenburger M; Dicato M; Diederich M
    Pharmacol Res; 2018 Mar; 129():337-356. PubMed ID: 29133216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine: A key metabolic junction in targeted tumor therapy.
    Wang X; Gong W; Xiong X; Jia X; Xu J
    Pharmacol Res; 2024 Aug; 206():107292. PubMed ID: 39002867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.
    Wang S; Fu JL; Hao HF; Jiao YN; Li PP; Han SY
    Pharmacol Res; 2021 Aug; 170():105728. PubMed ID: 34119622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment.
    Ayoub NM; Siddique AB; Ebrahim HY; Mohyeldin MM; El Sayed KA
    Eur J Pharmacol; 2017 Sep; 810():100-111. PubMed ID: 28625568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies.
    Wang Y; Xie Q; Tan H; Liao M; Zhu S; Zheng LL; Huang H; Liu B
    Pharmacol Res; 2021 Nov; 173():105702. PubMed ID: 34102228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
    Martins-Neves SR; Cleton-Jansen AM; Gomes CMF
    Pharmacol Res; 2018 Nov; 137():193-204. PubMed ID: 30316903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.